BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 37669846)

  • 1. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Factors Associated With Gender-Affirming Surgery Among Transgender Women & Transgender Men in a Community-Based Clinic in Metro Manila, Philippines: A Retrospective Study.
    Eustaquio PC; Castelo AV; Araña YS; Corciega JOL; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    Sex Med; 2022 Apr; 10(2):100497. PubMed ID: 35247792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
    Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
    Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
    Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
    J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
    Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
    Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-uptake of HIV testing among trans men and trans women: cross-sectional study of client records from 2017 to 2019 in a community-based transgender health center in Metro Manila, Philippines.
    Regencia ZJG; Castelo AV; Eustaquio PC; Araña YS; Corciega JOL; Rosadiño JDT; Pagtakhan RG; Baja ES
    BMC Public Health; 2022 Sep; 22(1):1755. PubMed ID: 36114481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and gender affirming healthcare needs of transgender and non-binary students starting hormone therapy in a student health service in Aotearoa New Zealand.
    Carroll R; Sepulveda B; McLeod L; Stephenson C; Carroll RW
    J Prim Health Care; 2023 Jun; 15(2):106-111. PubMed ID: 37390028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
    Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
    Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment.
    Mazzoli F; Cassioli E; Ristori J; Castellini G; Rossi E; Cocchetti C; Romani A; Angotti T; Giovanardi G; Mosconi M; Lingiardi V; Speranza AM; Ricca V; Vignozzi L; Maggi M; Fisher AD
    J Endocrinol Invest; 2022 Nov; 45(11):2059-2068. PubMed ID: 35779204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
    Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
    Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study.
    Rutnin S; Suchonwanit P; Kositkuljorn C; Pomsoong C; Korpaisarn S; Arunakul J; Rattananukrom T
    Transgend Health; 2023 Feb; 8(1):89-99. PubMed ID: 36824384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
    Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
    Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.